Recombinant ITGA4 (Natalizumab Biosimilar) antibody

Catalog No. ABIN7597845

This Humanized Chimeric antibody specifically detects ITGA4 (Natalizumab Biosimilar) in . It exhibits reactivity toward Human.

Quick Overview for Recombinant ITGA4 (Natalizumab Biosimilar) antibody (ABIN7597845)

Target: ITGA4 (Natalizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This ITGA4 (Natalizumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-ITGA4 (Natalizumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Natalizumab Biosimilar Antibody

Specificity: ITGA4, CD49d, CD49 antigen-like family member D, CD49D, VLA-4 subunit alpha, Integrin alpha-IV, Integrin alpha-4

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG4 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for ITGA4 (Natalizumab Biosimilar)

Target: ITGA4 (Natalizumab Biosimilar)

Alternative Name: Natalizumab Biosimilar

Target Type: Biosimilar

Background: ITGA4, CD49d, CD49 antigen-like family member D, CD49D, VLA-4 subunit alpha, Integrin alpha-IV, Integrin alpha-4

UniProt: P13612

CAS-No: 189261-10-7